Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-02-21 Purchase | 2024-02-22 1:38 pm | InMed Pharmaceuticals Inc. | INM | HULL ANDREW Director | 37,500 | $0.39 | $14,625 | 38,258 (Direct) | View |
| 2024-02-20 Purchase | 2024-02-21 2:58 pm | InMed Pharmaceuticals Inc. | INM | ADAMS ERIC A President & CEO | 41,600 | $0.3587 | $14,922 | 43,959 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-14 Expired | 2024-03-05 3:20 pm | 2019-01-14 2024-01-14 | InMed Pharmaceuticals Inc. | INM | HULL ANDREW Director | 42 | $0 | 8,542 (Direct) | View |
| 2024-03-04 Expired | 2024-03-05 3:20 pm | 2019-03-04 2024-03-04 | InMed Pharmaceuticals Inc. | INM | HSU ERIC C Sr. VP, Pre-Clinical Res/Dev | 309 | $0 | 52,545 (Direct) | View |
| 2024-01-21 Expired | 2024-03-05 3:20 pm | 2019-01-21 2024-01-21 | InMed Pharmaceuticals Inc. | INM | MANCINI ALEXANDRA DIANE JANET Sr VP, Clinical Reg Affairs | 121 | $0 | 52,485 (Direct) | View |
Ownership | 2024-02-27 3:27 pm | 2024-02-20 2029-02-19 | InMed Pharmaceuticals Inc. | INM | Jagpal Netta Chief Financial Officer | 0 | $0 | 50,000 (Direct) | View |
| 2023-12-23 Option Award | 2023-12-26 1:09 pm | N/A 2028-12-22 | InMed Pharmaceuticals Inc. | INM | Johnson Shane Aaron Sr VP & General Manager | 40,000 | $0 | 48,000 (Direct) | View |
| 2023-12-23 Option Award | 2023-12-26 1:09 pm | N/A 2028-12-22 | InMed Pharmaceuticals Inc. | INM | Lemerond Nicole Director | 7,100 | $0 | 8,500 (Direct) | View |
| 2023-12-23 Option Award | 2023-12-26 1:09 pm | N/A 2028-12-22 | InMed Pharmaceuticals Inc. | INM | WOUDENBERG MICHAEL Chief Operating Officer | 65,000 | $0 | 75,494 (Direct) | View |
| 2023-12-23 Option Award | 2023-12-26 1:08 pm | N/A 2028-12-22 | InMed Pharmaceuticals Inc. | INM | Tegge Jonathan Interim CFO | 30,000 | $0 | 31,400 (Direct) | View |
| 2023-12-23 Option Award | 2023-12-26 1:08 pm | N/A 2028-12-22 | InMed Pharmaceuticals Inc. | INM | Grove Janet P Director | 7,100 | $0 | 8,500 (Direct) | View |
| 2023-12-23 Option Award | 2023-12-26 1:07 pm | N/A 2028-12-22 | InMed Pharmaceuticals Inc. | INM | HSU ERIC C Sr. VP, Pre-Clinical Res/Dev | 45,000 | $0 | 52,854 (Direct) | View |
| 2023-12-23 Option Award | 2023-12-26 1:07 pm | N/A 2028-12-22 | InMed Pharmaceuticals Inc. | INM | ADAMS ERIC A President & CEO | 136,000 | $0 | 162,139 (Direct) | View |
| 2023-12-23 Option Award | 2023-12-26 1:05 pm | N/A 2028-12-22 | InMed Pharmaceuticals Inc. | INM | Baldasare Bryan T Director | 7,100 | $0 | 8,500 (Direct) | View |
| 2023-12-23 Option Award | 2023-12-26 1:04 pm | N/A 2028-12-22 | InMed Pharmaceuticals Inc. | INM | MANCINI ALEXANDRA DIANE JANET Sr VP, Clinical Reg Affairs | 45,000 | $0 | 52,606 (Direct) | View |
| 2023-12-23 Option Award | 2023-12-26 1:04 pm | N/A 2028-12-22 | InMed Pharmaceuticals Inc. | INM | HULL ANDREW Director | 7,100 | $0 | 8,584 (Direct) | View |
| 2023-12-05 Expired | 2023-12-06 09:02 am | 2018-12-05 2023-12-05 | InMed Pharmaceuticals Inc. | INM | WOUDENBERG MICHAEL Chief Operating Officer | 848 | $0 | 10,494 (Direct) | View |
| 2023-08-31 Expired | 2023-08-31 5:22 pm | 2018-08-31 2023-08-31 | InMed Pharmaceuticals Inc. | INM | HSU ERIC C Sr. VP, Pre-Clinical Res/Dev | 327 | $0 | 7,854 (Direct) | View |
| 2023-05-16 Expired | 2023-05-16 6:00 pm | 2018-05-16 2023-05-16 | InMed Pharmaceuticals Inc. | INM | HSU ERIC C Sr. VP, Pre-Clinical Res/Dev | 152 | $0 | 8,181 (Direct) | View |
| 2023-05-16 Expired | 2023-05-16 5:59 pm | 2018-05-16 2023-05-16 | InMed Pharmaceuticals Inc. | INM | MANCINI ALEXANDRA DIANE JANET Sr VP, Clinical Reg Affairs | 485 | $0 | 7,606 (Direct) | View |
| 2023-05-16 Expired | 2023-05-16 5:58 pm | 2018-05-16 2023-05-16 | InMed Pharmaceuticals Inc. | INM | ADAMS ERIC A President & CEO | 1,818 | $0 | 26,139 (Direct) | View |
| 2023-03-08 Expired | 2023-03-09 3:47 pm | 2018-03-08 2023-03-08 | InMed Pharmaceuticals Inc. | INM | MANCINI ALEXANDRA DIANE JANET Sr VP, Clinical Reg Affairs | 61 | $0 | 8,091 (Direct) | View |
| 2023-03-08 Expired | 2023-03-09 3:45 pm | 2018-03-08 2023-03-08 | InMed Pharmaceuticals Inc. | INM | HSU ERIC C Sr. VP, Pre-Clinical Res/Dev | 545 | $0 | 8,333 (Direct) | View |
| 2023-03-08 Expired | 2023-03-09 3:43 pm | 2018-03-08 2023-03-08 | InMed Pharmaceuticals Inc. | INM | ADAMS ERIC A President & CEO | 545 | $0 | 27,957 (Direct) | View |
| 2022-12-16 Option Award | 2022-12-19 5:08 pm | N/A 2027-12-15 | InMed Pharmaceuticals Inc. | INM | Lemerond Nicole Director | 840 | $0 | 1,400 (Direct) | View |
| 2022-12-16 Option Award | 2022-12-19 5:04 pm | N/A 2027-12-15 | InMed Pharmaceuticals Inc. | INM | Tegge Jonathan Interim CFO | 1,400 | $0 | 1,400 (Direct) | View |
| 2022-12-16 Option Award | 2022-12-19 5:03 pm | N/A 2027-12-15 | InMed Pharmaceuticals Inc. | INM | Li Sarah VP Accounting & Controller | 3,600 | $0 | 4,002 (Direct) | View |
| 2022-12-16 Option Award | 2022-12-19 4:59 pm | N/A 2027-12-15 | InMed Pharmaceuticals Inc. | INM | Johnson Shane Aaron Sr VP & General Manager | 4,200 | $0 | 8,000 (Direct) | View |
| 2022-12-16 Option Award | 2022-12-19 4:58 pm | N/A 2027-12-15 | InMed Pharmaceuticals Inc. | INM | WOUDENBERG MICHAEL Chief Operating Officer | 7,500 | $0 | 11,342 (Direct) | View |
| 2022-12-16 Option Award | 2022-12-19 4:54 pm | N/A 2027-12-15 | InMed Pharmaceuticals Inc. | INM | Grove Janet P Director | 840 | $0 | 1,400 (Direct) | View |
| 2022-12-16 Option Award | 2022-12-19 4:51 pm | N/A 2027-12-15 | InMed Pharmaceuticals Inc. | INM | HULL ANDREW Director | 840 | $0 | 1,484 (Direct) | View |
| 2022-12-16 Option Award | 2022-12-19 4:50 pm | N/A 2027-12-15 | InMed Pharmaceuticals Inc. | INM | Baldasare Bryan T Director | 840 | $0 | 1,400 (Direct) | View |
| 2022-12-16 Option Award | 2022-12-19 4:50 pm | N/A 2027-12-15 | InMed Pharmaceuticals Inc. | INM | ADAMS ERIC A President & CEO | 15,000 | $0 | 28,502 (Direct) | View |
| 2022-12-16 Option Award | 2022-12-19 4:49 pm | N/A 2027-12-15 | InMed Pharmaceuticals Inc. | INM | HSU ERIC C Sr. VP, Pre-Clinical Res/Dev | 4,200 | $0 | 8,878 (Direct) | View |
| 2022-12-16 Option Award | 2022-12-19 4:47 pm | N/A 2027-12-15 | InMed Pharmaceuticals Inc. | INM | MANCINI ALEXANDRA DIANE JANET Sr VP, Clinical Reg Affairs | 4,200 | $0 | 8,152 (Direct) | View |
Ownership | 2022-11-29 6:58 pm | 2022-01-12 2025-01-25 | InMed Pharmaceuticals Inc. | INM | Li Sarah VP, Accounting and Controller | 0 | $0 | 402 (Direct) | View |
| 2022-11-14 Disposition(A) | 2022-11-18 7:36 pm | N/A 2027-11-13 | InMed Pharmaceuticals Inc. | INM | Johnson Shane Aaron Sr VP & General Manager | 4,200 | $0 | 3,800 (Direct) | View |
| 2022-11-14 Disposition(A) | 2022-11-18 7:35 pm | N/A 2027-11-13 | InMed Pharmaceuticals Inc. | INM | MANCINI ALEXANDRA DIANE JANET Sr VP, Clinical Reg Affairs | 4,200 | $0 | 3,952 (Direct) | View |
| 2022-11-14 Disposition(A) | 2022-11-18 7:35 pm | N/A 2027-11-13 | InMed Pharmaceuticals Inc. | INM | HSU ERIC C Sr. VP, Pre-Clinical Res/Dev | 4,200 | $0 | 4,678 (Direct) | View |